Amarin Corp Plc (AMRN)

[kvenne]

You wrote:

"The timing of an interim look later than today's date put's efficacy > 15% even if you consider an unrealistic placebo rate way less than 5.2%. At 5.2% placebo rate efficacy will hover around 40%. This is greater than many not as well run statin trials. The life cycle of Vascepa is defined...greater than $100 Billion life cycle."

Great reply but I am not so sure Wall Street believes this boards statistical analysis as much as we all do here (excluding Mog, kiwi, ladavis). So does Wall Street wait for interum analysis to remove any doubt?

OR

Is Wall street now starting to run there own statistical analysis now that the 967 event is upon us and will they see the light and start to buy in as I believe you are stating?

Well at least we are both in the no NCE camp and I can see it being used as a bargaining chip to gain anchor SPA.

Thanks for the replies always a pleasure.